Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

… treat uncomplicated malaria ·    This novel combination also contains an … falciparum. Ganaplacide is a novel agent with a new … artemisinin-based medicines with novel mechanisms of action against … Venture (MMV) and Singapore Economic Development Board supported …